MedCity News

NOVEMBER 27, 2022

The biotech’s Series D financing round lays the groundwork to bring its lead program into the clinic in mid-2023, as well as support development of the rest of its pipeline of peptide drugs. FogPharma is preclinical, but not for long.

Leads 119

Leads Biopharma Pharma 119

MedCity News

OCTOBER 13, 2023

Health tech to support care for seniors and track the progression of conditions such as Parkinson’s disease and heart failure were on display at HLTH 2023. The National Institute on Aging also added a startup boot camp leading up to HLTH.

Leads 122

Leads Medicine 122

European Pharmaceutical Review

JANUARY 29, 2024

N-Nitrosamines By far the biggest issue bedevilling industry during 2023 was the continuing N-nitrosamine contamination saga, which was covered in the third issue of EPR 2023. During August 2023 the FDA also updated its guidance for NDSRIs 7 and it was closely aligned (but not identical) to EMA’s evolving guidance.

Pharmaceutical 111

Pharmaceutical Food and Drug Administration Medicine FDA 111

PM360

MAY 15, 2023

Environmental Champions: Individuals or teams who are leading environmental or sustainability efforts within their organization or even outside of their day jobs. Read more Digital Crusaders ELITE 2023 Digital Crusader Don Abramo of Pharming Healthcare Inc. Transformational Leaders: People who change the way companies operate.

Education 105

Education Media Marketing Sales 105

European Pharmaceutical Review

OCTOBER 10, 2023

Data showed that TEAEs leading to treatment discontinuation were more frequent with quetiapine XR (11.0 Nasal spray could help prevent depression relapse The post ECNP 2023: new esketamine NS safety data for depression appeared first on European Pharmaceutical Review. There were 53.6 percent of quetiapine XR-treated patients.

Safety 109

Safety Leads Patients Pharmaceutical 109

European Pharmaceutical Review

APRIL 13, 2023

INTERPHEX 2023 is right around the corner, taking place April 25-27 at the Javits Center in NYC. INTERPHEX is set to bring leading brands and professionals together once again with new features, a reimagined Show Floor and returning Show Floor favourites. Register for FREE here.

Education 98

Education Pharmaceutical products Pharma Training 98

pharmaphorum

JANUARY 6, 2023

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023. Data will unlock clinical and economic value in Europe’s challenging landscape.

Safety 111

Safety Management Patients Training 111

European Pharmaceutical Review

MAY 29, 2023

A neurosteroid drug was one of two medicines recommended for approval at the Committee for Medicinal Products for Human Use (CHMP) ’s May 2023 meeting. This outcome was based on trial results, which compared the effectiveness and safety of Adakveo with placebo in patients who had previously had painful crises leading to a healthcare visit.

Medicine 98

Medicine Marketing Leads Safety 98

pharmaphorum

DECEMBER 23, 2022

And in 2023, these investments will hopefully pay off. Leading companies will empower their teams to act quickly, compliantly, and with a unified view of the HCP.”. In 2023, omnichannel behaviours will directly influence incentive compensation models by correlating successful engagement data to successful sales outcomes.

Marketing 105

Marketing Sales Medical Patients 105

Clarivate

FEBRUARY 27, 2024

Would 2023 data show a second year of decline, indicating uncertain economic outlooks? It covers a commercial market with 27 member countries, a population of over 450 million people (larger than the United States), and an economy estimated to have a combined GDP of over $ 18 trillion USD in 2023 (larger than Mainland China).

Marketing 98

Marketing Leads Management 98

European Pharmaceutical Review

AUGUST 21, 2023

For 20 of the leading biopharmaceutical companies, the second quarter (Q2) of 2023 has brought an aggregate market capitalisation growth of 2.3 trillion in the Q1 of 2023 to $3.56 trillion in Q2 2023. billion to revenue in Q2 2023. billion to revenue in Q2 2023. billion in Q2 2023. percent.

Biopharma 98

Biopharma Marketing Sales Medicine 98

pharmaphorum

JANUARY 26, 2023

2023 is set to usher in a new era of genomics, and here are five areas where we should see significant advances. Just one mutation can lead to a complete change in protein formation. The post A new dawn of the genomic age: five areas set to be transformed in 2023 appeared first on.

Pharmacology 129

Pharmacology Government Leads Physicians 129

Pharmaceutical Technology

MAY 30, 2023

According to GlobalData’s Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 are projected to attain blockbuster status or near-blockbuster status by 2028 with US company dominance. These drugs are set to make a combined $4.34bn in sales in 2028. Similarly, Almirall S.A.,

Sales 105

Sales Marketing Prescription Pharma 105

Clarivate

NOVEMBER 15, 2023

Today, we present our 2023 list , recognizing 6,849 individuals from more than 1,300 institutions across 67 countries and regions. By implementing an increasing number of qualitative criteria and markers this year, the number of preliminary candidates excluded from our final list increased from 500 in 2022 to more than 1,000 for 2023.

Networking 130

Networking Consulting Management Leads 130

PM360

APRIL 18, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for its annual international conference, ISPOR 2023. ISPOR is recognized globally as the leading professional society for health economics and outcomes research and for its role in improving healthcare decisions.

Electronics 97

Electronics Healthcare Healthcare Medicine 97

European Pharmaceutical Review

OCTOBER 23, 2023

Janssen Pharmaceutical Companies of Johnson & Johnson’s data were featured at the European Society for Medical Oncology (ESMO) 2023 Congress. Martin Vogel, EMEA Therapeutic Area Lead Oncology, Janssen-Cilag GmbH highlighted that “standard-of-care for BCG-unresponsive HR-NMIBC is radical cystectomy”.

Pharmaceutical 111

Pharmaceutical Safety Patients Leads 111

European Pharmaceutical Review

OCTOBER 2, 2023

The Nobel Assembly has awarded Hungarian biochemist Katalin Karikó and US immunologist Drew Weissman the Nobel Prize in Physiology or Medicine 2023 for their breakthrough findings in RNA vaccine development. This leads to their activation and the release of inflammatory signalling molecules.

Medicine 111

Medicine Pharmaceutical Pharma Leads 111

Healthcare Success

DECEMBER 6, 2022

In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. 9 Healthcare Marketing Trends 2023. Be sure to include staff recruitment in your 2023 marketing budget. Here’s to a successful 2023.

Healthcare 113

Healthcare Healthcare Marketing Competition 113

pharmaphorum

JANUARY 5, 2023

The drive to make the UK a ‘scientific powerhouse’ was central to the government’s announcement closing out 2022 , which appointed five industry experts to lead on the sectors most vital to UK’s future innovation. The post It’s time for more tech and biotech innovation in 2023 appeared first on. About the author. He holds a B.S.

Manufacturing 105

Manufacturing Government Leads Electronics 105

European Pharmaceutical Review

NOVEMBER 9, 2023

MANUFACTURING Continuous direct compression: opening up faster access to oral dose medication Deborah McElhone, CPI’s Medicines Manufacturing Innovation Centre IN-DEPTH FOCUS: QA/QC MICROBIOLOGY Bioburden and sterility testing: how to conserve gene therapy product Kathy Zagaroli, Senior Director of Quality Control at Kiniksa Pharmaceuticals Tom Bujold, (..)

Pharmaceutical 98

Pharmaceutical Manufacturing Medicine Management 98

pharmaphorum

JANUARY 27, 2023

It’s wise advice from the “Sage of Omaha”; indeed, one highly respected financial newspaper began its 2023 predictions by conceding that it had been wrong on five major counts for 2022. Demand has also increased due to changes in prescribing protocols, leading to a higher underlying number of prescriptions for certain antibiotic medicines.

Medicine 105

Medicine Government Marketing Transportation 105

Pharmaceutical Technology

MAY 2, 2024

From Merck & Co to Sanofi, Pharmaceutical Technology lists the leading pharmaceutical companies spending the most on R&D in 2023.

Pharmaceutical 124

Pharmaceutical Leads 124

Copyright Clearance Center

AUGUST 29, 2023

CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, announces that its President and CEO, Tracey Armstrong, was named to the Forbes 2023 “ 50 Over 50 ” list. The post Tracey Armstrong Named to Forbes 2023 “50 Over 50” List appeared first on Copyright Clearance Center.

Leads 98

Leads 98

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. When production at the 17,200-ft 2 site begins, currently anticipated for the end of Q3 2023, the facility will further enhance bioproduction capabilities and contribute to the growth of the sector in France and Europe.

Pharmaceutical manufacturing 104

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 104

PM360

OCTOBER 3, 2023

Diversity/Multicultural: Anna Czene, Vice President, Corporate Communications & DEI Lead, CareDx, Inc. Gastrointestinal: Lindsay Bensko, Director, IBD Education and Engagements, Takeda Pharmaceuticals Global Marketing: Lisa Green, Director, Global Marketing ‑ Rare Diseases, Chiesi Global Rare Diseases HCP Engagement: Jibin John, Sr.

Education 122

Education Marketing Media Pharmaceutical 122

MedCity News

JUNE 22, 2023

In the 12 months leading up to May 15, health services deal volumes decreased just 4% from the year prior, a new report from PwC found. There was a 15% decrease in deal values.

Healthcare 110

Healthcare Healthcare Leads 110

Spotio

FEBRUARY 27, 2023

Sales Effectiveness Sales effectiveness refers to your sales team’s ability to convert prospects into leads — and eventually paying customers or clients — at each stage of your sales funnel. That is, how quickly you are able to convert users into leads/sales and while still generating the highest return on your investment.

Sales 103

Sales Sales process Prospecting CRM 103

European Pharmaceutical Review

JUNE 27, 2023

This data was presented at the 2023 Fetal Medicine Foundation (FMF) World Congress in Spain. Dr Ludovic de Beaucoudrey, Therapeutic Area Lead for Immunology Janssen EMEA shared more about nipocalimab with EPR What is the mechanism of action for nipocalimab? There were 12 of the 13 pregnancies (92 percent) that resulted in a live birth.

Side effects 98

Side effects Engineering Manufacturing Medicine 98

Spotio

JULY 25, 2023

HubSpot – This all-in-one platform helps sales and marketing teams attract more site visitors, convert more leads, and close more sales. Establish lead qualification criteria Almost 80% of leads never turn into sales. But you can improve your B2B conversion rates with a structured approach to analyzing your leads.

B2B Sales 98

B2B Sales Sales Prospecting Sales process 98

MedCity News

SEPTEMBER 19, 2023

The Federal Trade Commission doesn’t get notified about every deal, which can lead to a slow consolidation of the market, said Lina Khan, chair of the FTC. She made these comments on Monday during the Oliver Wyman Health Innovation Summit 2023 held in Chicago.

Healthcare 126

Healthcare Healthcare Leads Marketing 126

MedCity News

MAY 22, 2023

Ironwood Pharmaceuticals is paying $1 billion to acquire VectivBio, a biotech whose lead program could become a blockbuster treatment for a gastrointestinal disorder. Preliminary Phase 3 data are expected by the end of 2023.

Pharmaceutical 118

Pharmaceutical Leads Biopharma Pharma 118

European Pharmaceutical Review

NOVEMBER 30, 2023

Cell and gene therapy industry in 2023 According to data from the GMP Manufacturing Survey, in the past year: “There is an increase in the number of manufacturing organisations and the number of licensed facilities has remained stable. The 2023 data found that the split for bioprocessing roles was 57 percent.

Manufacturing 97

Manufacturing Recruitment Medicine Biopharma 97

PM360

JULY 13, 2023

Jay Patel From our experience in patient research across many different treatments, we’ve defined several key insights on what may lead to nonadherence: Complex medication routines and patients feeling overwhelmed with their regimen. Inconvenient or challenging-to-adhere-to medications that have complex administration methods.

Patients 98

Patients Medical Education Transportation 98

European Pharmaceutical Review

JANUARY 18, 2024

An attractive destination for ATMP clinical trials Based on the Cell and Gene Therapy Catapult (CGT Catapult)’s recently published UK 2023 Advanced Therapy Medicinal Product (ATMP) Clinical Trials Database , the UK is an attractive location for ATMP clinical trials. There were 175 ongoing trials in 2023, compared to 178 in 2022.

Distribution 111

Distribution Manufacturing Medicine Government 111

Pharmaceutical Technology

JUNE 24, 2024

from 2023 to 2032, reaching $17.9bn across the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) by the end of this forecast period, according to leading data and analytics company GlobalData’s recent report: Osteoporosis: Seven-Market Drug Forecast and Market Analysis.

Marketing 105

Marketing Leads 105

MedCity News

JUNE 1, 2023

Healthcare IT companies experienced a bounceback in venture capital deal activity during Q1 of 2023. Rebecca Springer, PitchBook ’s lead healthcare analyst, said she is optimistic that healthcare IT startups will be able to keep this momentum going, especially those focused on staffing and value-based care enablement.

Healthcare 111

Healthcare Healthcare Leads 111

Pharmaceutical Technology

JUNE 26, 2024

In this issue: UK’s new Netflix-style funding model for antibiotics, the Swiss biotech ecosystem recuperates from financial instability of 2023, how patient advocacy can lead to more successful clinical trials, and more.

Leads 96

Leads Patients 96